- Newsletter
- May 2024
Global
From €1010EUR$1,124USD£899GBP
- Report
- March 2024
- 196 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- March 2024
- 199 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- April 2020
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- September 2020
- 106 Pages
Global
From €1916EUR$1,990USD£1,648GBP
- Book
- March 2021
- 400 Pages
From €159EUR$165USD£137GBP
- Report
- July 2018
- 765 Pages
Global
From €21186EUR$22,000USD£18,221GBP
- Report
- February 2022
- 120 Pages
United States
From €2408EUR$2,500USD£2,071GBP
- Report
- May 2021
- 82 Pages
Global
€21186EUR$22,000USD£18,221GBP
- Report
- November 2018
- 53 Pages
Global
From €8181EUR$8,495USD£7,036GBP
- Report
- August 2018
- 164 Pages
Global
From €5778EUR$6,000USD£4,969GBP
- Report
- February 2020
- 40 Pages
Saudi Arabia
From €2499EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
Japan
From €2499EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
South Korea
From €2499EUR$2,595USD£2,149GBP
- Report
- February 2020
- 40 Pages
India
From €2499EUR$2,595USD£2,149GBP
- Report
- June 2023
- 73 Pages
Global
From €3500EUR$3,893USD£3,115GBP
- Report
- June 2021
- 87 Pages
Global
From €3200EUR$3,560USD£2,848GBP
- Report
- February 2020
- 40 Pages
United States
From €2499EUR$2,595USD£2,149GBP
Multiple Sclerosis (MS) is a chronic, progressive neurological disorder that affects the central nervous system. It is classified as an autoimmune disorder, meaning that the body's immune system mistakenly attacks healthy tissue. MS is a major area of research within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of the disease. Treatment options for MS include medications, physical therapy, and lifestyle modifications.
MS is a major health concern, with an estimated 2.3 million people living with the condition worldwide. Symptoms of MS can vary greatly from person to person, and can include fatigue, vision problems, muscle spasms, and difficulty with balance and coordination.
Companies in the MS market include Biogen, Novartis, Sanofi, Merck, and Teva Pharmaceuticals. Show Less Read more